drugset / Trial / NCT02898961

Impact of 30 mg/kg Amikacin and 8 mg/kg Gentamicin on Serum Concentrations in Critically Ill Patients With Severe Sepsis

NCT02898961

Phase 4 Completed 63 enrolled Nîmes University Hospital
NaSingle-groupOpen-labelTreatment

Summary

Low first-dose peak serum concentrations of amikacin and gentamicin are commonly reported in ICU patients. The present study aimed to assess whether 30 mg/kg amikacin or 8 mg/kg gentamicin achieved target concentrations in ICU patients with severe sepsis.

Timeline

Start
2014-10
Primary completion
2016-12-31
Completion
2016-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Amikacin Small molecule 30 mg/kg Intravenous
Subject Gentamicin Small molecule 8 mg/kg Intravenous